Hyperliquid Strategies Files Pro Forma Financials for Sonnet Acquisition, Revealing Significant HYPE Token Loss and IPR&D Expensing

summarizeSummary

Hyperliquid Strategies Inc. filed an amended 8-K providing pro forma financial statements for its acquisition of Sonnet BioTherapeutics, detailing a significant net loss, a large HYPE token valuation loss, and immediate expensing of IPR&D.

check_boxKey Events

• Pro Forma Net Loss Reported

  The unaudited pro forma condensed combined financial statements show a net loss of $86.9 million for the year ended September 30, 2025, with a pro forma net loss per share of $0.68.

• Significant Loss on HYPE Token Contribution

  The company recognized a $169.2 million loss on HYPE token contribution commitment, reflecting the difference between the fair value of HYPE tokens at the commitment date and the closing date of the acquisition.

• Acquired IPR&D Immediately Expensed

  A $33.2 million in-process research and development (IPR&D) asset acquired from Sonnet was immediately expensed, impacting the company's reported financial results.

• Dilution from Transaction Fees

  The business combination involved the issuance of 9.94 million shares and 27.39 million warrants for advisor and placement agent fees, contributing to significant dilution.

auto_awesomeAnalysis

This 8-K/A provides critical financial details for the previously announced business combination where Hyperliquid Strategies Inc. (HSI) acquired Sonnet BioTherapeutics Holdings, Inc. and Rorschach I LLC. The filing reveals a substantial pro forma net loss of $86.9 million for the year ended September 30, 2025, and a significant $169.2 million loss related to the HYPE token contribution commitment. Additionally, $33.2 million in acquired in-process research and development (IPR&D) was immediately expensed, impacting reported earnings. The transaction also involved considerable dilution through the issuance of shares and warrants for advisory fees. These financial disclosures highlight the substantial costs and accounting impacts of the acquisition and the volatility associated with HYPE digital assets, reinforcing concerns about the company's financial health following recent reports of HYPE depreciation.